Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Takeda oncology

Challenges in oncology R&D – part 2

November 25, 2015 Manufacturing and Production, Research and Development R&D, Takeda, oncology

Pharmafile put questions on the challenges pharma companies face when working in oncology R&D to Dixie-Lee Esseltine, vice president of …
Feature
Medicines Patent Pool

BMS and Medicines Patent Pool collaborate to increase Hep C medicine access

November 25, 2015 Manufacturing and Production, Research and Development Bristol-Myers Squibb, Medicines Patent Pool, daclatasvir, daklinza, hepatitis C

The Medicines Patent Pool (MPP) has announced its first licence for a hepatitis C medicine, signing an agreement with Bristol-Myers …
News
Teva image

Teva and Heptares enter $400m agreement for small-molecule migraine treatment

November 25, 2015 Research and Development Heptares, Teva, collaboration, migraine

Teva Pharmaceuticals and Heptares Therapeutics have signed a licensing and drug-discovery agreement for Teva to gain exclusive global rights to …
News
Dementia scan

UK commits £150 million to new Dementia Research Institute

November 25, 2015 Research and Development dementia. R&D

The UK government has launched plans for a new £150 million dementia research institute that it says will drive a …
News
BMS

Bristol-Myers Squibb in new oncology collaboration

November 25, 2015 Research and Development Bristol-Myers Squibb, collaboration, immuno-oncology, investment, venture capital

Bristol-Myers Squibb and European healthcare fund Life Sciences Partners are forming a strategic collaboration to identify breakthrough technologies.  The companies …
News
nick_plaquetec_c-4

PlaqueTec appoints Dr Nick West as CMO

November 24, 2015 Research and Development PlaqueTec

PlaqueTec has appointed Dr Nick West as its new chief medical officer.  Dr West is a research-active clinician with extensive …
Appointment
opdivo

FDA approves BMS’s Opdivo for renal cell carcinoma

November 24, 2015 Research and Development

The FDA has approved Bristol Myers Squibb’s immunotherapy Opdivo for the treatment of patients with advanced renal cell carcinoma (RCC). …
News
Arzerra

Genmab pulls plug on Phase III Arzerra trial

November 24, 2015 Manufacturing and Production, Research and Development Arzerra, Genmab, non-Hodgkin's lymphoma, non-Hodgkin’s lymphoma, ofatumumab, phase III, phase III failure

Genmab has stopped a Phase III study of its CD20-directed monoclonal antibody Arzerra, after it was shown to be unlikely …
News

OmniaMed UK appoints new senior management

November 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

OmniaMed has strengthened its senior management team by appointing Dr Clive Deverson as managing director and Dr Colin Griffin as …
Appointment
merck-sharp--dohme-corp

MSD launches new antibiotic in the UK

November 23, 2015 Manufacturing and Production, Research and Development

Merck (MSD) has launched the new intravenous antibiotic Zerbaxa (ceftolozane/tazobactam) in the UK, for the treatment of complicated intra-abdominal infections …
News
tablets_red

Take the Pharmafocus reader survey today

November 23, 2015 Manufacturing and Production, Research and Development

As a valued reader of Pharmafocus, you regularly receive print copies of our market-leading newspaper and have access to the digital …
Feature
pfizer_hq_new_york_dark

Pfizer and Allergan confirm record $160 billion merger

November 23, 2015 Manufacturing and Production, Research and Development

Pfizer and Allergan have confirmed a $160 billion merger, unanimously approved by their boards of directors, creating the world’s largest …
News
Takeda oncology

FDA approves Takeda’s Ninlaro for multiple myeloma

November 23, 2015 Manufacturing and Production, Research and Development Takeda, myeloma

The US Food and Drug Administration (FDA) has approved Takeda’s Ninlaro (ixazomib) for use in combination with lenalidomide and dexamethasone …
News
cosentyx_logo

Novartis bags two EU Cosentyx approvals

November 23, 2015 Research and Development, Sales and Marketing

The European Commission (EC) has approved Novartis’ Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and …
News
amgen_flag

European Commission approves Amgen’s cancer drug Kyprolis in combo therapy

November 20, 2015 Research and Development, Sales and Marketing

The European Commission (EC) has today granted marketing authorization for Amgen’s Kyprolis (carfilzomib) in combination with lenalidomide and dexamethasone for …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025